These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22987950)

  • 21. Conventional chemotherapy of advanced pancreatic cancer.
    Giuliani F; Di Maio M; Colucci G; Perrone F
    Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial].
    Sumii T; Funakoshi A; Mizumoto K; Tanaka M; Arita Y; Ito T; Yamaguchi H; Ueki T; Sakai T; Miyahara T; Muranaka T; Igarashi H; Shinozaki H; Eriguchi N
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):603-6. PubMed ID: 18408428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of metastatic pancreatic cancer.
    Ko AH; Tempero MA
    J Natl Compr Canc Netw; 2005 Sep; 3(5):627-36. PubMed ID: 16194454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer. Breaching the cancer fortress.
    Olson P; Hanahan D
    Science; 2009 Jun; 324(5933):1400-1. PubMed ID: 19520948
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase 1 trials in pancreatic cancer.
    Yu E; Saif MW; Huber K
    JOP; 2014 Jul; 15(4):326-8. PubMed ID: 25076334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients.
    Corrie P; Mayer A; Shaw J; D'Ath S; Blagden S; Blesing C; Price P; Warner N
    Br J Cancer; 2002 Sep; 87(7):716-9. PubMed ID: 12232752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.
    Neuzillet C; Hentic O; Rousseau B; Rebours V; Bengrine-Lefèvre L; Bonnetain F; Lévy P; Raymond E; Ruszniewski P; Louvet C; Hammel P
    World J Gastroenterol; 2012 Sep; 18(33):4533-41. PubMed ID: 22969226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
    Stathopoulos GP; Syrigos K; Aravantinos G; Polyzos A; Papakotoulas P; Fountzilas G; Potamianou A; Ziras N; Boukovinas J; Varthalitis J; Androulakis N; Kotsakis A; Samonis G; Georgoulias V
    Br J Cancer; 2006 Sep; 95(5):587-92. PubMed ID: 16909140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas].
    Obayashi K; Ohwada S; Sunose Y; Yamamoto K; Igarashi R; Hamada K; Takeyoshi I; Horiuchi R
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1915-7. PubMed ID: 19011342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.
    Zhang XW; Ma YX; Sun Y; Cao YB; Li Q; Xu CA
    Target Oncol; 2017 Jun; 12(3):309-321. PubMed ID: 28353074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
    Gourgou-Bourgade S; Bascoul-Mollevi C; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Boige V; Bérille J; Conroy T
    J Clin Oncol; 2013 Jan; 31(1):23-9. PubMed ID: 23213101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).
    André T; Noirclerc M; Hammel P; Meckenstock R; Landi B; Cattan S; Selle F; Codoul JF; Guerrier-Parmentier B; Mokhtar R; Louvet C;
    Gastroenterol Clin Biol; 2004; 28(8-9):645-50. PubMed ID: 15646530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First line therapy for metastatic pancreatic cancer.
    Jarboe J; Saif MW
    JOP; 2013 Jul; 14(4):340-3. PubMed ID: 23846923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study.
    Guo JC; Yang SH
    Int J Clin Oncol; 2014 Aug; 19(4):634-42. PubMed ID: 24077663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.
    Davis EJ; Griffith KA; Kim EJ; Ruch JM; McDonnell KJ; Zalupski MM
    Am J Clin Oncol; 2018 Feb; 41(2):128-132. PubMed ID: 26535993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].
    Sasajima J; Tanno S; Koizumi K; Nakano Y; Habiro A; Chiba A; Fujii T; Sugiyama Y; Nakamura K; Nishikawa T; Mizukami Y; Okumura T; Kohgo Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1657-61. PubMed ID: 19838023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.
    Fujita T
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577725
    [No Abstract]   [Full Text] [Related]  

  • 39. What options are available for refractory pancreatic cancer?
    Choi M; Kim R; Saif MW
    JOP; 2012 Mar; 13(2):163-5. PubMed ID: 22406591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gemzar (gemcitabine)--a new chemotherapeutic agent for pancreatic cancer].
    Merimsky O; Chaitchik S
    Harefuah; 1997 Sep; 133(5-6):208-12. PubMed ID: 9461693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.